PAPER Maher PA

Using Plants as a Source of Potential Therapeutics for the Treatment of Alzheimer's Disease.

Yale J Biol Med. 2020 Jun;93(2):365-373. Epub 2020 Jun 29 PubMed.

PAPER Lee JY, Wong CY, Koh RY, Lim CL, Kok YY, Chye SM

Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review.

Yale J Biol Med. 2024 Jun;97(2):205-224. Epub 2024 Jun 28 PubMed.

PAPER Chen Y, Chen XC

[Possible mechanisms of the protective effect of ginsenoside Rg1 on apoptosis in substantia nigra neurons].

Yao Xue Xue Bao. 2002 Apr;37(4):249-52. PubMed.

PAPER Xu YG, Zhang JX, Hua WY, Zhu DY

[Synthesis and nNOS inhibitory activity of benzenealkyl isothiourea compounds].

Yao Xue Xue Bao. 2003 Aug;38(8):586-91. PubMed.

PAPER Pan YP, Xu XH, Wang XL

[mRNA expression alteration of two-pore potassium channels in the brain of beta-amyloid peptide25-35-induced memory impaired rats].

Yao Xue Xue Bao. 2003 Oct;38(10):721-4. PubMed.

PAPER Shen LH, Zhang JT

[Culture of neural stem cells from cerebral cortex of rat embryo and effects of drugs on the proliferation ability of stem cells].

Yao Xue Xue Bao. 2003 Oct;38(10):735-8. PubMed.

PAPER Zhang GR, Gao DL, Cao LG, Yin M

[5-HT2C receptor subtype modulate production of secretory beta-amyloid protein precursor in incubated rat hippocampal slices].

Yao Xue Xue Bao. 2004 May;39(5):321-4. PubMed.

PAPER Zhang YJ, Guo Y, Jia QZ, Wang YL, Zhang HL

Mechanism of anti-apoptotic action of dipfluzine on neuronal damage of the rat hippocampal CA1 region subjected to transient forebrain ischemia.

Yao Xue Xue Bao. 2005 Feb;40(2):97-104. PubMed.

PAPER Zeng YQ, Chen XC, Zhu YG, Li YK, Peng XS, Chen LM, Shen J, Huang TW

[Ginsenoside Rbl attenuates beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons].

Yao Xue Xue Bao. 2005 Mar;40(3):225-30. PubMed.

PAPER Zhang YJ, Mei HS, Wang C, Wang YL

Involvement of nuclear factor of activated T-cells (NFATc) in calcineurin-mediated ischemic brain damage in vivo.

Yao Xue Xue Bao. 2005 Apr;40(4):299-305. PubMed.

PAPER Kong LN, Geng MY, Mu L, Xin XL, Yang N, Zuo PP

[Effects of acidic oligose on differentially expressed genes in the mice model of Alzheimer's disease by microarray].

Yao Xue Xue Bao. 2005 Dec;40(12):1105-9. PubMed.

PAPER Xie YH, Chen XC, Zhang J, Huang TW, Song JQ, Fang YX, Pan XD, Lin ZY

[Ginsenoside Rb1 attenuates beta-amyloid peptide(25-35)-induced hyperphosphorylation of tau protein through CDK5 signal pathway].

Yao Xue Xue Bao. 2007 Aug;42(8):828-32. PubMed.

PAPER Zhang J, Cheng Y, Zhang JT

[Protective effect of (-) clausenamide against neurotoxicity induced by okadaic acid and beta-amyloid peptide25-35].

Yao Xue Xue Bao. 2007 Sep;42(9):935-42. PubMed.

PAPER Zhu Y, Tong XY, Zhao Y, Chen H, Jiang FC

Construction of the pharmacophore model of acetylcholinesterase inhibitor.

Yao Xue Xue Bao. 2008 Mar;43(3):267-76. PubMed.

PAPER Hou Y, Bao XQ, Liu GT

[The role of vitagene in aging and Alzheimer's disease and relevant advances of pharmacological study].

Yao Xue Xue Bao. 2009 Aug;44(8):825-32. PubMed.